Pulse pressure and selected biochemical predictors of cardiovascular complications in primary hypertension;Ciśnienie tȩtna a wybrane biochemiczne czynniki ryzyka powikłań sercowo-naczyniowych u chorych na nadciśnienie tȩtnicze pierwotne

Nadcisnienie Tetnicze

Volumn 10, Issue 3, 2006, Pages 190-196

  Sławuta, Agnieszka ^a   Witkowska, Maria ^a  

^a Wroclaw Medical University Katedra i Klinika Kardiologii   (Poland)

Author keywords

Creatinine clearance; Creatinine level; Fibrinogen; Glucose level; Lipid metabolism; Microalbuminuria; Pulse pressure

Indexed keywords

CHOLESTEROL; CREATININE; FIBRINOGEN; GLUCOSE; LIPID;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HUMAN; HYPERTENSION; LIPID METABOLISM; MAJOR CLINICAL STUDY; MICROALBUMINURIA; PULSE PRESSURE; RISK FACTOR;

EID: 33747616448     PISSN: 14285851     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Darne B., Girend X., Safar M., Cambien F., Guize L. Pulsatile Versus Steady Component of Blood Pressure: A Cross-sectional Analysis and a Prospective Analysis on Cardiovascular Mortality. Hypertens. 1989; 13: 392-400.
2. Vaccarino V., Holford T.R., Harlan M., Krumholz B. Pulse pressure and risk for myocardial infarction and heart failure in the elderly. J. Am. Coll. Cardiol. 2000; 36: 130-138.
3. Zasady postȩpowania w nadciśnieniu tȩtniczym - Stanowisko Polskiego Towarzystwa Nadciśnienia Tȩtniczego 2003. Nadciśnienie Tȩtnicze 2003; 7 (supl. A): A1-A21.
4. Brunner F.P., Selwood N.H. on behalf of the EDTA Registration Committee. Profile of patients on RRT in Europe and death rates due to major causes of death groups. Kidney Int. 1992; 42 (supl. 38): S4-S15.
5. Rostand S.G., Brown G., Kirk KA, Rutsky E.A., Dustan H.P. Renal insufficiency in treated essential hypertension. N. Engl. J. Med. 1989; 320: 684-688.
6. Schulman N.B., Ford C.E., Hall W.D. i wsp. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Resultes from hypertension detection and follow-up program. Hypertension 1989; 13 (supl. I): 80-93.
7. Siewert-Delle A, Ljungman S., Andersson O.K., Wilhelmsen L. Does treated primary hypertension lead to end-stage renal disease? A 20-year follow-up of the Primary Prevension Study in Goteborg, Sweden. Nephrol. Dial. Transplant. 1998; 13: 3084-3090.
8. Gatzka C.D., Cameron J.D., Kingwell B.A., Dart A.M. Relation between coronary artery disease, aortic stiffness, and left ventricular structure in a population sample. Hypertension 1998; 32: 575-578.
9. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med. 1999; 130: 461-470.
10. Gerstein H.C., Mann J.F., Yi Q. i wsp. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421-426.
11. Ravera M., Ratto E., Vettoretti S. i wsp. Microalbuminuria and subclinical cerebrovascular damage in essential hypertension. J. Nephrol. 2002; 15: 519-524.
12. Cirillo M., Stellato D., Laurenzi M., Panarelli W., Zanchetti A., De Santo N.G. Pulse pressure and isolated systolic hypertension: assocoation with microalbuminuria. The GUBBIO Study Collaborative Research Group. Kidney Int. 2000; 58 (3): 1211-1218.
13. Haffner S.M., Stern M.P., Gruber M.K., Hazuda H.P., Mitchell B.D., Patterson J.K. Micoralbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis 1990; 10 (5): 727-731.
14. Reaven G.M., Lithell H., Landsberg L. Hypertension and Associated Metabolic Abnormalities - The Role of Insulin Resistance and the Sympathoadrenal System. N. Engl. J. Med. 1996; 334: 374-381.
15. Dart A.M., Lacombe F., Yeoh J.K. Aortic distensibility in patients with isolated hypercholesterolemia, coronary artery disease or cardiac transplant. Lancet 1991; 338: 270-273.
16. Lehman E.W., Watts G.F., Gosling G.S. Aortic distensibility and hypercholesterolemia. Lancet 1992; 340: 1171-1172.
17. Farrar D.J., Bond M.G., Riley W.A., Sawyer J.K. Anatomic correlates of aortic pulse wave velocity and carotid artery elasticity during atherosclerosis progression and regression in monkeys. Circulation 1991; 83: 1754-1763.
18. Newman D.L., Gosling R.G., Bowden N.L. Changes in aortic distensibility and area ratio with the development of atherosclerosis. Atherosclerosis 1971; 14: 231-240.
19. Antikainen R., Jousilahti P., Vanhanen H., Tuomilehto J. Excess mortality associated with increased pulse pressure among middle-aged men and women is explained by high systolic blood pressure. J. Hypertens. 2000; 18: 417-423.
20. Cosentino F., Hishikawa K., Katusic Z.S., Luscher T.F. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial stress. Circulation 1997; 96: 25-28.
21. Beckeman J.A., Goldfine A.B., Gordon M.B., Garret L.A., Creager M.A. Inhibition of protein kinase Cβ prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ. Res. 2002; 90: 107-111.
22. Vane J.R., Anggard E.E., Botting R.M. Regulatory functions of the vascular endothelium. N. Engl. J. Med. 1990; 323: 27-38.
23. Panza J.A., Quyyumi A.A., Callahan T.S., Epstein S.E. Effect of antihypertensive treatment on endothelium-dependent vescular relaxation in patients with essential hypertension. J. Am. Coll. Cardiol. 1993; 21: 1145-1151.
24. Taddei S., Virdis A., Mattei P., Arzilli F., Salveti A. Endothelium-dependent forearm vasodilation is reduced in normotensive subjects with familial history of hypertension. J. Cardiovasc. Pharmacol. 1992; 20: S193-S195.
25. Lechi C., Gaino S., Zuliani V. Elevated plasma fibrynogen levels in patients with essential hypertension are related to vascular complications. Intern. Angiol. 2003; 22: 72-78.
26. Sechi L.A., Zingaro L., Caterna C. Relationship of fibrinogen levels and hemostatic abnormalities with organ damage in hypertension. Hypertension 2000; 36: 978-985.